Pie Huda

411 total citations
18 papers, 221 citations indexed

About

Pie Huda is a scholar working on Biomaterials, Radiology, Nuclear Medicine and Imaging and Biomedical Engineering. According to data from OpenAlex, Pie Huda has authored 18 papers receiving a total of 221 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Biomaterials, 7 papers in Radiology, Nuclear Medicine and Imaging and 7 papers in Biomedical Engineering. Recurrent topics in Pie Huda's work include Nanoparticle-Based Drug Delivery (8 papers), Monoclonal and Polyclonal Antibodies Research (5 papers) and Nanoplatforms for cancer theranostics (5 papers). Pie Huda is often cited by papers focused on Nanoparticle-Based Drug Delivery (8 papers), Monoclonal and Polyclonal Antibodies Research (5 papers) and Nanoplatforms for cancer theranostics (5 papers). Pie Huda collaborates with scholars based in Australia, Denmark and Singapore. Pie Huda's co-authors include Kristofer J. Thurecht, Christopher B. Howard, Stephen M. Mahler, Nicholas L. Fletcher, Anna Cifuentes‐Rius, Marcin Wojnilowicz, Lea Barfod, Werner Streicher, Saikat Ghosh and Christian Fercher and has published in prestigious journals such as PLoS ONE, Biomaterials and Chemical Communications.

In The Last Decade

Pie Huda

17 papers receiving 221 citations

Peers

Pie Huda

BIOMA

RNMI

PHEOH

Changhui Yu China

Puja Sapra United States

M. Graham United States

James Trevor Oswald Canada

Xiaoxiao Wang China

Alexander H. J. Staal Netherlands

Maliheh Hajiramezanali Iran

Xue Shan China

Suzanne Einmahl Switzerland

Erik Őrfi Hungary

Changhui Yu China

Pie Huda

132 ×1.5

89 ×1.5

BIOMA

56 ×1.2

65 ×1.5

RNMI

15 ×0.4

PHEOH

Citations per year, relative to Pie Huda Pie Huda (= 1×) peers Changhui Yu

Countries citing papers authored by Pie Huda

Since Specialization

Citations

This map shows the geographic impact of Pie Huda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pie Huda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pie Huda more than expected).

Fields of papers citing papers by Pie Huda

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pie Huda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pie Huda. The network helps show where Pie Huda may publish in the future.

Co-authorship network of co-authors of Pie Huda

This figure shows the co-authorship network connecting the top 25 collaborators of Pie Huda. A scholar is included among the top collaborators of Pie Huda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pie Huda. Pie Huda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Hobson‐Peters, Jody, Saikat Ghosh, Christopher B. Howard, et al.. (2025). Multiplexing Label-Free Polymeric Nanocarriers via Antipolymer Antibodies. ACS Sensors. 10(2). 1280–1288.

Howard, Christopher B., Pie Huda, Nicholas L. Fletcher, et al.. (2025). Immune-modulating nanomedicines for enhanced drug delivery to non-small-cell lung cancer. Biomaterials. 317. 123089–123089. 1 indexed citations

Howard, Christopher B., Pie Huda, Kathleen Kimpton, et al.. (2024). Targeted delivery of polo-like kinase 1 siRNA nanoparticles using an EGFR-PEG bispecific antibody inhibits proliferation of high-risk neuroblastoma.. Journal of Controlled Release. 367. 806–820. 12 indexed citations

Ghosh, Saikat, Nicholas L. Fletcher, Pie Huda, et al.. (2023). Pharmacokinetics and Biodistribution of ⁸⁹Zr-Miltuximab and Its Antibody Fragments as Glypican-1 Targeting Immuno-PET Agents in Glioblastoma. Molecular Pharmaceutics. 20(3). 1549–1563. 7 indexed citations

Ghosh, Saikat, et al.. (2023). RAFT Polymer–Antibody Conjugation: Squaramide Ester Chemistry Leads to Conjugates with a Therapeutic Anti-EGFR Antibody with Full Retention of Activity and Increased Tumor Uptake In Vivo. Molecular Pharmaceutics. 20(6). 3073–3087. 2 indexed citations

Chu, Weijing, Zachary H. Houston, Nicholas L. Fletcher, et al.. (2023). Development and Validation of a Targeted Treatment for Brain Tumors Using a Multi-Drug Loaded, Relapse-Resistant Polymeric Theranostic. Biomacromolecules. 24(6). 2674–2690. 4 indexed citations

Huda, Pie, et al.. (2023). Click‐on Antibody Fragments for Customisable Targeted Nanomedicines – Site‐specific Tetrazine and Azide Functionalisation through Non‐canonical Amino Acid incorporation. Chemistry - Methods. 4(2). 1 indexed citations

Fletcher, Nicholas L., et al.. (2022). Development of targeted micelles and polymersomes prepared from degradable RAFT-based diblock copolymers and their potential role as nanocarriers for chemotherapeutics. Polymer Chemistry. 13(27). 4004–4017. 3 indexed citations

Ghosh, Saikat, Pie Huda, Nicholas L. Fletcher, et al.. (2022). Antibody-Based Formats to Target Glioblastoma: Overcoming Barriers to Protein Drug Delivery. Molecular Pharmaceutics. 19(5). 1233–1247. 3 indexed citations

10.

Janowicz, Phillip W., Zachary H. Houston, Jens Bunt, et al.. (2022). Understanding nanomedicine treatment in an aggressive spontaneous brain cancer model at the stage of early blood brain barrier disruption. Biomaterials. 283. 121416–121416. 22 indexed citations

11.

Fletcher, Nicholas L., Pie Huda, Saikat Ghosh, et al.. (2022). Pre-targeting of polymeric nanomaterials to balance tumour accumulation and clearance. Chemical Communications. 58(57). 7912–7915. 15 indexed citations

12.

Gao, Zhiliang, Xiaoyu Li, Kaijie Zhao, et al.. (2022). Confined microemulsion sono-polymerization of poly(ethylene glycol) nanoparticles for targeted delivery. Chemical Communications. 58(56). 7777–7780. 10 indexed citations

13.

Ghosh, Saikat, Pie Huda, Nicholas L. Fletcher, et al.. (2022). Clinical development of an anti-GPC-1 antibody for the treatment of cancer. Expert Opinion on Biological Therapy. 22(5). 603–613. 6 indexed citations

14.

Fercher, Christian, et al.. (2020). Targeting the undruggable: emerging technologies in antibody delivery against intracellular targets. Expert Opinion on Drug Delivery. 17(9). 1189–1211. 32 indexed citations

15.

Tieu, Terence, Marcin Wojnilowicz, Pie Huda, et al.. (2020). Nanobody-displaying porous silicon nanoparticles for the co-delivery of siRNA and doxorubicin. Biomaterials Science. 9(1). 133–147. 37 indexed citations

16.

Arleth, Lise, Grethe Vestergaard Jensen, Pie Huda, et al.. (2017). Combined SAXS and microfludics for time-resolved structural studies of biomolecules. Acta Crystallographica Section A Foundations and Advances. 73(a2). C609–C609. 2 indexed citations

17.

Huda, Pie, Tina Binderup, Martin Cramer Pedersen, et al.. (2015). PET/CT Based In Vivo Evaluation of 64Cu Labelled Nanodiscs in Tumor Bearing Mice. PLoS ONE. 10(7). e0129310–e0129310. 18 indexed citations

18.

Huda, Pie, J. Alexandra Rowe, Alister Craig, et al.. (2014). Investigating the function of F_c-specific binding of IgM toPlasmodium falciparumerythrocyte membrane protein 1 mediating erythrocyte rosetting. Cellular Microbiology. 17(6). 819–831. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact